Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (43)

2023

  1. Clinical Profiling and Biomarkers for Post-Operative Atrial Fibrillation Prediction in Patients Undergoing Cardiac Surgery

    Journal of Clinical Medicine, Vol. 12, Núm. 10

  2. Differential prognosis of patients that are candidates for standard, short or prolonged dual antiplatelet treatment discharged after an acute coronary syndrome

    Thrombosis Research, Vol. 224, pp. 46-51

  3. Remnant cholesterol in patients admitted for acute coronary syndromes

    European journal of preventive cardiology, Vol. 30, Núm. 4, pp. 340-348

2022

  1. Differences Between Takotsubo and the Working Diagnosis of Myocardial Infarction With Nonobstructive Coronary Arteries

    Frontiers in Cardiovascular Medicine, Vol. 9

  2. Early angiography in elderly patients with non-ST-segment elevation acute coronary syndrome: The cardio CHUS-HUSJ registry

    International Journal of Cardiology, Vol. 351, pp. 8-14

  3. Longer-Term Results of a Universal Electronic Consultation Program at the Cardiology Department of a Galician Healthcare Area

    Circulation. Cardiovascular quality and outcomes, Vol. 15, Núm. 1, pp. e008130

  4. Prognostic impact of renal function trajectories in patients with STEMI and kidney dysfunction undergoing primary percutaneous coronary intervention: An analysis of ten years all-comers registry

    Hellenic Journal of Cardiology, Vol. 66, pp. 1-10

  5. Should PRECISE-DAPT be included for long-term prognostic stratification of diabetic patients with NSTEACS?

    Acta Diabetologica, Vol. 59, Núm. 2, pp. 163-170

2021

  1. A New Biomarker Tool for Risk Stratification in “de novo” Acute Heart Failure (OROME)

    Frontiers in Physiology, Vol. 12

  2. Cost and potential savings of electronic consultation and its relationship with reduction in atmospheric pollution

    Sustainability (Switzerland), Vol. 13, Núm. 22

  3. Long term prognostic benefit of complete revascularization in elderly presenting with NSTEMI: Real world evidence

    Reviews in Cardiovascular Medicine, Vol. 22, Núm. 2, pp. 475-482

  4. New-onset heart failure after acute coronary syndrome in patients without heart failure or left ventricular dysfunction

    Revista Espanola de Cardiologia, Vol. 74, Núm. 6, pp. 494-501

  5. Prognostic benefit from an early invasive strategy in patients with non-ST elevation acute coronary syndrome (NSTEACS): evaluation of the new risk stratification in the NSTEACS European guidelines

    Clinical Research in Cardiology, Vol. 110, Núm. 9, pp. 1464-1472

  6. Prognostic impact of left ventricular ejection fraction recovery in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: Analysis of an 11-year all-comers registry

    European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 8, pp. 898-908

  7. Sex differences in the management of patients with acute coronary syndrome: A population-based ecological cross-sectional study in Spain

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 168-178

2020

  1. Atrial fibrillation and ischemic heart disease: beyond stroke prevention

    Revista Espanola de Cardiologia Suplementos, Vol. 20, pp. 11-20

  2. CD5L, Macrophage Apoptosis Inhibitor, Was Identified in Epicardial Fat-Secretome and Regulated by Isoproterenol From Patients With Heart Failure

    Frontiers in Physiology, Vol. 11

  3. High released lactate by epicardial fat from coronary artery disease patients is reduced by dapagliflozin treatment

    Atherosclerosis, Vol. 292, pp. 60-69

  4. Long-term bleeding risk vs. mortality risk in acute coronary syndrome patients according to the 2019 ARC-HBR definition

    Thrombosis Research

  5. Prediction of major adverse cardiac, cerebrovascular events in patients with diabetes after acute coronary syndrome

    Diabetes and Vascular Disease Research, Vol. 17, Núm. 1